
Objective: To examine the association between retrospectively reported childhood environmental unpredictability and bedtime procrastination among undergraduate medical students in South India.Methods: This single-center cross-sectional online survey included 200 undergraduate medical students. Bedtime procrastination was assessed using the nine-item Bedtime Procrastination Scale (BPS; range, 9–45), and childhood unpredictability using the 38-item Questionnaire of Unpredictability in Childhood (QUIC; range, 0–38). Because the BPS has no validated diagnostic cutoff, scores were analyzed continuously. The primary analysis used Spearman rank correlation with bootstrap confidence intervals (CI), and robust linear regression was used to quantify the association. An additional multivariable model adjusted for age, sex, academic year, residence, and socioeconomic category.Results: The mean age was 18.8 years (standard deviation [SD], 1.1), and 67.0% of participants were women. Mean BPS and QUIC scores were 27.93 (SD, 7.19) and 9.39 (SD, 5.53), respectively. Overall QUIC score was weakly associated with BPS score (Spearman rho=0.242; 95% bootstrap confidence interval, 0.111–0.366; p<0.001). After adjustment for age, sex, academic year, residence, and socioeconomic category, a five-point higher QUIC score was associated with a 1.48-point higher mean BPS score (95% CI, 0.52–2.43; p=0.003). Three parental domains showed small exploratory associations after false-discovery-rate adjustment.Conclusion: Childhood environmental unpredictability showed a small positive association with bedtime procrastination. The cross-sectional, retrospective findings are hypothesis-generating and do not establish causality.
Objective: To test whether sex modifies the association between habitual sleep duration and health outcomes in middle-aged Korean adults.Methods: We analyzed cross-sectional data from 3,709 participants in the Ansan arm of the Korean Genome and Epidemiology Study Phase 2 (2003–2004). Sleep duration was calculated as a weighted 7-day average and categorized as short (<7 hr), reference (7 to <9 hr), or long (≥9 hr). Primary outcomes were body mass index, fasting plasma glucose, a fatigue-related symptom score, and forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio. The primary analysis tested the sleep category×sex interaction using 2-df likelihood-ratio tests adjusted for age, income, marital status, occupation, smoking, drinking, and exercise. Secondary outcomes were controlled using the Benjamini–Hochberg false discovery rate.Results: In the primary fully adjusted model, sleep duration×sex interactions were not significant for body mass index (p=0.930), fasting glucose (p=0.388), fatigue-related symptom score (p=0.104), or FEV1/FVC ratio (p=0.855). A complementary short-versus-reference 1-df interaction contrast was nominally significant for fatigue-related symptom score (p=0.047). In an explicitly post hoc age-stratified analysis, the fatigue-related symptom score interaction was concentrated among participants aged <50 years (p=0.001): short sleep was associated with higher adjusted fatigue-related symptom scores in women (+4.75 points; 95% confidence interval [CI], +2.33 to +7.16) but not in men (-0.50; 95% CI, -2.52 to +1.52).Conclusion: This analysis found no evidence of broad sex modification for cardiometabolic or pulmonary outcomes. The younger-adult fatigue-related symptom score signal should be considered hypothesis-generating pendingreplication with validated fatigue measures and longitudinal data. The fatigue-related symptom score used in this study was not a validated fatigue instrument, which limits the interpretability of the fatigue findings.
Objective: Conventional investigations into vaccination scheduling have relied on fixed clock time, which fails to account for individual circadian phase. This study investigated the feasibility of exploring the hypothesis that an individual’s circadian phase at the time of vaccination is related to antibody response rather than time of day alone.Methods: Twenty healthy adults (aged 20–28) underwent continuous wrist actigraphy monitoring for 14 days using the Corsano Cardiowatch 287-2B. Participants were randomized to morning (08:00–09:00 am) or afternoon (4:00–5:00 pm) influenza vaccination times. Circadian profiles were constructed using cosinor modeling of biomarkers. Hemagglutination inhibition assays quantified H1N1 and H3N2 antibody titers at baseline and 30 days post-vaccination. Regression analyses evaluated associations between circadian phase at the time of vaccination and antibody response.Results: Cortisol peak phase difference at time of vaccination had a positive association with antibody magnitude for both H1N1 and H3N2 strains (H1N1: R2=0.516, p=0.001; H3N2: R2=0.344, p= 0.012). Heart rate variability (HRV) trough phase difference at the time of vaccination had a negative association with antibody magnitude for H1N1 and H3N2 strains (H1N1: R2=0.636, p=0.001; H3N2: R2=0.616, p=0.001). No significant differences were found in antibody magnitude between morning and afternoon vaccination groups.Conclusion: Circadian phase of cortisol and HRV, estimated using wrist actigraphy, may be associated with differences in antibody response to the influenza vaccine. These preliminary findings support further investigation into the relationship between individual circadian timing and adaptive immune function.
Circadian disruption is increasingly recognized as a contributing factor in both chronic disease and impaired antitumor immunity; however, these two fields have largely evolved independently. We conducted a Scale for the Assessment of Narrative Review Articles-guided narrative review of PubMed, Scopus, and Google Scholar covering the period from 1993 through 2026, screening 550 records and critically appraising 167 eligible studies across five circadian mechanisms: immune, metabolic, oxidative-genomic, neuroendocrine, and tumor-intrinsic regulation. Core clock components, including BMAL1, CLOCK, and the Period and Cryptochrome gene families, coordinate cell-cycle progression, DNA repair, metabolic flux, and immune oscillation. Disruption of these mechanisms compromises tissue homeostasis and antitumor surveillance. Circadian misalignment promotes inflammation, oxidative stress, and metabolic dysregulation associated with cardiometabolic, neurodegenerative, and respiratory diseases, while the same mechanisms remodel the tumor microenvironment and reduce tumor-infiltrating lymphocytes in preclinical models. Clinical evidence in cancer remains preliminary and is derived largely from retrospective cohorts and clinical trials demonstrating improved treatment tolerability rather than survival benefit. Interventions that restore circadian alignment—including timed light exposure, time-restricted eating, and structured sleep schedules—have demonstrated benefits in randomized trials for selected chronic conditions, whereas cancer chronotherapy remains largely at the preclinical stage. Overall, circadian biology represents a mechanistic crosswalk linking chronic disease susceptibility with antitumor immune regulation. Future priorities include the development of standardized biomarkers of circadian disruption, prospective immunotherapy-timing trials powered to assess survival outcomes, and the expansion of chronotherapy protocols to cancer types that remain unexplored.